|
E.V. Biryukova, M.V. Shinkin, I.A. Morozovа
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
|
№3 / 2023
|
|
N.P. Lyamina (1), A.V. Kosareva (2)
The justified position of rosuvastatin in therapeutic practice
|
№9 / 2019
|
|
T.A. Rozhkova, V.I. Kaminnaya, M.Yu. Zubareva
THE USE OF ROSUVASTATIN IN PATIENTS WITH HYPERCHOLESTEROLEMIA (IIA AND IIB TYPE HYPERLIPDEMIA, FAMILIAL HYPERCHOLESTERINEMIA) IN CLINICAL OUTPATIENT PRACTICE
|
№10 / 2017
|
|
Z.G. Luginova (1), O.A. Pogorelova (1), M.I. Tripoten (1), M.V. Koshurnikova (1), T.V. Kuznetsova (1), V.P. Masenko (1), Yu.G. Matchin (1), T.V. Balakhonova (1), A.V. Susekov (2)
MAIN RESULTS OF RANDOMIZED TRIAL "FREGAT"*: EFFECT OF SHORT-TERM INTENSIVE ROSUVASTATIN THERAPY ON CAROTID ATHEROSCLEROSIS IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK.
|
№18 / 2016
|
|
N.P. Lyamina
STATIN THERAPY IN THE COMPLEX OF REHABILITATION AND SECONDARY PREVENTION MEASURES IN PATIENTS WITH CORONARY ARTERY DISEASE
|
№13 / 2016
|
|
F.N. Chavdar, Yu. V. Kovaleva, A.P. Maslov, M.N. Baranova, N.V. Ryzhkova, L.N. Bazhenova, Z.V. Getman
EFFECTS OF SHORT-TERM THERAPY WITH ROSUVASTATIN ON LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE
|
№16 / 2014
|
|
A.I. Kaminny, Yu.A. Shuvalova, T.A. Shishova, V.I.Kaminnaya, V.S. Tutunov, D.I. Soboleva, V.V. Kukharchuk
THE EFFICACY AND SAFETY OF THERAPY WITH ROSUVASTATIN. THE RESULTS OF 8-WEEK "5 TO 40" STUDY
|
№13 / 2014
|
|
Yu.A. Bochenina, G.E. Kuznetsov, L.R. Tenchurina
DYNAMICS OF THE MARKERS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE DURING TREATMENT WITH ROSUVASTATIN
|
№20 / 2013
|
|
Yu.A.Bochenina, G.E.Kuznetsov, L.R.Tenchurina
Effect Of Rosuvastatin On The Structural And Function Status Of Endothelium In Patients With Chronic Ischemic Heart Failure
|
№17 / 2012
|
Русский
